Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality
Ina Nemet(Cleveland Clinic Lerner College of Medicine), Stanley L. Hazen(Cleveland Clinic), Jennifer Wilcox(Cleveland Clinic Lerner College of Medicine), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), W.H. Wilson Tang(Cleveland Clinic), Fredrik Bäckhed(Sahlgrenska University Hospital), Xinmin S. Li(Cleveland Clinic), Michael A. Fischbach(Stanford University), Maximilian König(Charité - Universitätsmedizin Berlin), Ilja Demuth(Charité - Universitätsmedizin Berlin), Jennifer A. Buffa(Cleveland Clinic), Ulf Landmesser(Deutsches Herzzentrum der Charité), Lin Li(Cleveland Clinic), Marco Witkowski(Cleveland Clinic), Arash Haghikia(Vita-Salute San Raffaele University), Kymberleigh A. Romano(MACOM (United States))
Cited by 120
Related Papers
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k